{
    "SPADE_N_04897": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2009/0105151 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2009_0105151_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2009-4-23",
                "Family Info": "WO2009014615A2,WO2009014615A3",
                "Patent Title": "Amphipathic alpha-helical peptide compositions as antiviral agents.",
                "Abstract": "The invention features methods and compositions that exploit the ability of amphipathic alpha-helical (AH) peptides to cause disruption of lipid-containing vesicles, such as enveloped viruses, in a size-dependent manner."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_04897",
            "Sequence": "ELGFQPGLKVAQHLAYPVPDVP",
            "Sequence Length": 22,
            "Peptide Name": "Sequence 88 from Patent US 20090105151",
            "Source": "Hepatitis C virus",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Frequent Amino Acids": "PLV",
            "Absent Amino Acids": "CIMNORSTUW",
            "Basic Residues": 2,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 14,
            "Polar Residues": 10,
            "Positive Residues": 2,
            "Negative Residues": 2,
            "Mass": 2375.72,
            "PI": 5.32,
            "Net Charge": 0,
            "Hydrophobicity": 0.04,
            "Similar Sequences": []
        }
    }
}